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Loss-of-function mutations in glypican-3 (GPC3),
one of the six mammalian glypicans, causes the
Simpson-Golabi-Behmel overgrowth syndrome
(SGBS), and GPC3 null mice display developmental
overgrowth. Because the Hedgehog signaling path-
way positively regulates body size, we hypothesized
that GPC3 acts as an inhibitor of Hedgehog activity
during development. Here, we show that GPC3 null
embryos display increased Hedgehog signaling and
that GPC3 inhibits Hedgehog activity in cultured
mouse embryonic fibroblasts. In addition, we report
that GPC3 interacts with high affinity with Hedgehog
but not with its receptor, Patched, and that GPC3
competes with Patched for Hedgehog binding.
Furthermore, GPC3 induces Hedgehog endocytosis
and degradation. Surprisingly, the heparan sulfate
chains of GPC3 are not required for its interaction
with Hedgehog. We conclude that GPC3 acts as
a negative regulator of Hedgehog signaling during
mammalian development and that the overgrowth
observed in SGBS patients is, at least in part, the
consequence of hyperactivation of the Hedgehog
signaling pathway.
INTRODUCTION
Glypicans are a family of heparan sulfate proteoglycans (HSPG)
that are linked to the exocytoplasmic surface of the plasma
membrane through a glycosylphosphatidylinositol (GPI) anchor
(Filmus and Selleck, 2001). Six glypicans have been identified
in mammals (GPC1 to GPC6), and two in Drosophila (Dally and
Dally-like protein) (Paine-Saunders et al., 1999; Nakato et al.,
1995; Baeg et al., 2001). Glypicans are expressed predominantly
during development, in a stage- and tissue-specific manner,
suggesting that they play a role in morphogenesis (Song and Fil-
mus, 2002). Genetic and functional studies demonstrated that
glypicans regulate the signaling activity of various morphogens,
including Wnts, Hedgehogs (Hhs), bone morphogenic proteins
(BMP), and fibroblast growth factors (FGF) (Song et al., 1997;
Desbordes and Sanson, 2003; Ohkawara et al., 2003; Tsuda700 Developmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc.et al., 1999; Hagihara et al., 2000). In Drosophila, glypicans
have also been shown to mediate the transport of Hhs, Wnts,
and BMPs and are thus implicated in morphogen gradient
formation (Fujise et al., 2003; Lin, 2004; Desbordes and Sanson,
2003; Baeg et al., 2001).
Loss-of-function mutations of GPC3 are the cause of the
X-linked Simpson-Golabi-Behmel syndrome (SGBS) (Pilia
et al., 1996). This disorder is characterized by developmental
overgrowth and a broad spectrum of clinical manifestations
that vary from a verymild phenotype in carrier females to infantile
lethal form in males (Neri et al., 1998). The developmental abnor-
malities reported in affectedmales include enlarged tongue, cleft
palate, polydactyly, syndactyly, supernumerary nipples, cystic
and dysplastic kidneys, congenital heart defects, rib and verte-
bral fusions, and umbilical and inguinal hernias (Neri et al.,
1998). GPC3-deficient mice, which die at birth in the C57Bl/6
background, also display developmental overgrowth along
with several abnormalities found in the SGBS patients, including
cystic and dysplastic kidneys, and skeletal and ventral wall
defects (Cano-Gauci et al., 1999; Chiao et al., 2002). Because
cell sizes are similar in the GPC3 null mice and the normal litter-
mates, it has been concluded that the increase in body size in the
absence of GPC3 is the result of a higher cell proliferation rate
(Chiao et al., 2002). Consequently, it is reasonable to propose
that the developmental overgrowth of the SGBS patients and
the GPC3-deficient mice indicates that GPC3 acts as an inhibitor
of cell proliferation in the embryo. Additional support for a role of
GPC3 in the regulation of body size has been recently provided
by the finding that GPC3 polymorphisms have a significant
impact in the body size of mice (Oliver et al., 2005).
Because the insulin-like growth factor (IGF) signaling pathway
plays a key role in the regulation of body size during develop-
ment, it was initially proposed that GPC3 inhibits embryonic
growth by acting as a negative regulator of IGF activity (Pilia
et al., 1996). However, several studies performed by us and
others have failed to show any biochemical or genetic interaction
between GPC3 and the IGF signaling pathway (Chiao et al.,
2002; Song et al., 2005; Cano-Gauci et al., 1999).
We recently reported that GPC3 regulates Wnt signaling in
mouse embryos and in several cell lines (Song et al., 2005;
Capurro et al., 2005). However, since there is no genetic evidence
indicating that Wnt signaling controls body size, the mechanism
by which GPC3 regulates embryonic growth remains unknown.
Hedgehog (Hh) proteins activate a signaling pathway that
plays a very important role in the regulation of cell proliferation
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Glypican-3 Inhibits Hedgehog SignalingFigure 1. The Hh Signaling Pathway Is
Hyperactivated in GPC3 Null Mice
The relative levels of Patched andGli-1 transcripts
were determined by real-time PCR using b-actin
transcript levels as reference. A total of five litters:
one from E10.5 (four knockout [KO] and two wild-
type [WT]), two from E12.5 (both with two KO and
three WT) and two from E13.5 (two KO and two
WT; two KO and three WT) were analyzed inde-
pendently. For each litter, the relative expression
level for each transcript was normalized consider-
ing the lower wild-type value as 1. All ratios were
then plotted together. The bars represent the mean + SD for the indicated genotype. Each measurement was performed three times by duplicate. The average
of each measurement was used to calculate the relative expression levels.and differentiation in the embryo (Hooper and Scott, 2005; Nieu-
wenhuis and Hui, 2005; Wang et al., 2007; Ogden et al., 2004).
Three mammalian Hhs have been identified: Sonic (Shh), Indian
(Ihh), and Desert (Dhh) (Nieuwenhuis and Hui, 2005). Shh is
widely expressed in the embryo, and Ihh is expressed in devel-
oping bones. Dhh is restricted to Sertoli and Schwann cells. Se-
creted Hh binds and antagonizes the function of Patched (Ptc1),
a transmembrane receptor that blocks the activity of a signaling
effector called Smoothened. Thus, binding of Hh to Ptc1 results
in the activation of Smo, which in turn transduces the Hh signal
to the cytoplasm, ultimately leading to the activation of the Gli
family of transcription factors and the expression of Hh target
genes (Hooper and Scott, 2005). As expected, Ptc1-deficient
mice display a hyperactivation of the Hh signaling pathway.
Thesemice die at about day 9.5 of embryogenesis, but Ptc1 het-
erozygote mice are viable and are significantly larger than the
normal littermates (18.5 dpc embryos are 19% larger) (Makino
et al., 2001; Milenkovic et al., 1999). In humans, Ptc1 mutations
cause Gorlin’s Syndrome (Hahn et al., 1996). Like SGBS, Gorlin
patients display a body size larger than normal (Gorlin, 1995).
Taken together, these findings clearly indicate that the Hh signal-
ing pathway plays a critical role in the regulation of body size.
Because glypicans have already been implicated as regulators
of Hh signaling in Drosophila (Lum et al., 2003; Han et al., 2004;
Desbordes and Sanson, 2003), we hypothesized that GPC3 acts
as a negative regulator of body size by inhibiting Hh signaling
during mammalian development. Here, we present experimental
results that strongly support such hypothesis. Furthermore, our
data indicate that GPC3 inhibits Hh signaling by competing
with Ptc1 for Hh binding at the membrane and by inducing Hh
endocytosis and degradation.
RESULTS
GPC3 Inhibits Hh Pathway during Mouse Development
To test our hypothesis that GPC3 acts as a negative regulator of
Hh signaling during mammalian development, we compared the
degree of activation of the Hh signaling pathway in GPC3 null
mouse embryos and normal littermates. To this end, the relative
mRNA levels of two well-characterized Hh targets, Gli-1 and
Ptc1, were assessed by real-time RT-PCR. Because significant
overgrowth in the GPC3 null mice becomes detectable at
E12.5, we analyzed embryos from E10.5 to E13.5. Figure 1
shows that the expression levels of both Hh targets are signifi-
cantly elevated in GPC3-deficient mouse embryos comparedDto their normal littermates. We conclude, therefore, that the Hh
signaling pathway is activated in GPC3 null mice.
GPC3 Inhibits Hh Signaling in Mouse
Embryonic Fibroblasts
We also investigated the role of GPC3 on Hh signaling in cultured
cells. To this end, we performed transient expression assays in
NIH 3T3 mouse embryonic fibroblasts transfected with a lucifer-
ase reporter gene driven by an Hh-responsive promoter. As
shown in Figure 2, the transient expression of GPC3 in these
cells inhibited, in a dose-dependent manner, the luciferase activ-
ity induced by conditioned medium containing Shh (Figure 2A).
As expected, the Hh-interacting protein-1 (Hip1), a previously
identified Hh inhibitor (Chuang and McMahon, 1999), also
reduced Hh signaling (Figure 2A). GPC3 also inhibited the lucif-
erase activity induced in NIH 3T3 cells by coculture with 293T
cells expressing ectopic Ihh (Figure 2B). These results provide
additional support to the hypothesis that GPC3 acts as a nega-
tive regulator of the Hh signaling pathway.
Glypicans have been shown to regulate the signaling activity of
several ‘‘heparin-binding’’ growth factors through their heparan
sulfate (HS) chains (Steinfeld et al., 1996; Ai et al., 2003; Bon-
neh-Barkay et al., 1997). Because Hhs are known to interact
with HS (Zhang et al., 2007), and the inhibition of HS synthesis
inDrosophila alters Hh signaling (Lin, 2004), it has been assumed
that the Hh-regulatory activity of glypicans ismediated by the HS
chains (Baeg and Perrimon, 2000). We decided therefore to
investigate whether glycanation is required for the inhibitory ef-
fect of GPC3 on Hh. To this end, we assessed the effect of a mu-
tated GPC3 that cannot be glycanated (GPC3DGAG) (Gonzalez
et al., 1998) on Hh-induced transcriptional activity using the tran-
sient expression assay. Surprisingly, GPC3DGAG significantly
inhibited the response to Shh-conditioned medium (Figure 2C).
The inhibitory effect was lower than that of GPC3 wild-type,
indicating that whereas the HS chains are required for optimal
activity, the GPC3 core protein displays activity on its own.
Glypicans can be released from the cell surface by GPI-spe-
cific lipases (Kreuger et al., 2004).We decided therefore to inves-
tigate whether attachment to the cell membrane is required for
the inhibitory effect of GPC3 on Hh signaling. To this end, we as-
sessed the effect of a mutated GPC3 lacking the GPI-anchoring
domain (GPC3DGPI) (Gonzalez et al., 1998) on Shh-induced
luciferase activity. As shown in Figure 2D, GPC3DGPI was not
able to reduce Hh signaling, indicating that the attachment of
GPC3 to the cell surface is required for its inhibitory effect onevelopmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc. 701
Developmental Cell
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signaling if it is attached to the cell surface by a transmembrane
sequence. To this end, we used a GPC3-syndecan-1 fusion
protein where the GPI-anchoring domain of GPC3 was replaced
by the syndecan-1 transmembrane sequence (GPC3-Syn). As
shown in Figure 2E, transient expression of GPC3-Syn had no
inhibitory effect on Hh signaling.
GPC3 Interacts with Hh and Mediates the Binding
of Hh to Mouse Embryonic Fibroblasts
Next, we investigated themechanism by which GPC3 inhibits Hh
signaling. We hypothesized that GPC3 may compete with Ptc1
for Hh binding. To test this hypothesis, we investigated first
whether GPC3 is able to interact with Hh. To this end, we per-
formed coimmunoprecipitation experiments in 293T cells tran-
siently transfected with GPC3 and Shh. As shown in Figure 3A,
we found that these two proteins coimmunoprecipitate. On the
other hand, Shh did not coimmunoprecipitate with carcinoem-
bryonic antigen (CEA), a GPI-linked protein that has not been
implicated in the regulation of Hh signaling (Figure 3A). Next,
Figure 2. GPC3 Inhibits Hh Activity in
Mouse Embryonic Fibroblasts
(A) NIH 3T3 cells were transfected with the indi-
cated amounts of GPC3 or Hip1 expression
vectors or vector alone (EFor pCMV [0.6mg]), along
with a luciferase reporter vector driven by an Hh-
responsive promoter (8Xgli) (0.4 mg) and b-galacto-
sidase (50 ng), and stimulated for 48 hr with ShhN-
or control-conditionedmedium. A luciferase assay
was then performed. Bars represent fold
stimulation induced by Hh (average + SD of tripli-
cates). The experiment was repeated five times
with similar results.
(B) Ihh-induced luciferase reporter assay in NIH
3T3 cells transfected with the indicated vectors
(0.6 mg) plus the luciferase reporter and b-galacto-
sidase asdescribed above, but stimulated for 48 hr
by coculturing with 293T cells transfected with Ihh
or control vector.
(C–E) NIH 3T3 cells were transfected with the indi-
catedplasmids and stimulatedwithShh. The levels
of expression of the transfected proteins were an-
alyzed by western blot in (C) and by RT-PCR in (D).
b-actin was used as a loading control in (C), and as
a control of the amount of RNA in (D).
we used a coimmunoprecipitation experi-
ment to investigatewhether theHSchains
are required for the GPC3-Shh interac-
tion. As shown in Figure 3A, GPC3DGAG
also coimmunoprecipitates with Shh,
suggesting that the HS chains are not
required for the GPC3-Shh interaction. In
order to provide additional evidence for
the interaction between GPC3 and Shh,
we assessed the binding of a Shh-Alkaline
Phosphatase fusion protein (Shh-AP) to
membraneextracts of 293Tcells express-
ingGPC3orGPC3DGAG.Consistentwith
the coimmunoprecipitation results, we found that Shh-AP specif-
ically binds to themembraneextracts of cells expressingGPC3or
GPC3DGAG (Figure 3B). We validated the assay by showing that
Shh-AP also binds tomembrane extracts of cells transfectedwith
Ptc1, the Hh receptor (Figure 3C).
We also investigated whether Shh can bind to GPC3 in the
context of intact cells. To this end, we incubated Shh-containing
conditioned media with Light II cells that were transfected with
GPC3 or GPC3DGAG. After washing the unbound material, we
assessed the binding of Shh to the cells by immunostaining
with an anti-Shh antibody. As shown in Figure 3D, Shh strongly
bound to GPC3- and GPC3DGAG-transfected cells, whereas
no binding was detected in nontransfected cells. Although Light
II cells express endogenous Ptc1, the levels of expression must
be too low to be detected by the binding assay. Lack of detect-
able Shh binding in a similar assay has already been reported in
other cultured cells that are known to express endogenous Ptc1
(Incardona et al., 2000).
Next, the binding of Shh to GPC3 and GPC3DGAG was
characterized by Surface Plasmon Resonance (SPR) analysis.702 Developmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc.
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immobilized on a streptavidin (SA)-coated sensor chip, and
Shh solutions at various concentrations were injected across
the chip and then washed off in buffer. Figures 3E and 3F
show that Shh binds with similar high affinity to both GPC3
and GPC3DGAG, indicating the existence of a direct Shh-
GPC3 protein-protein interaction that does not require the HS
chains. This is consistent with recently published results show-
ing that Shh binds to HS with a Kd that is three orders of magni-
tude higher than that corresponding to the interaction with the
GPC3 core protein shown here (Zhang et al., 2007). No signifi-
cant binding of bovine serum albumin to GPC3-coated chip or
Shh to SA-coated chip was detected (Figures 3G and 3H).
Having established that membrane-bound GPC3 binds to
Shh, we sought to investigate whether GPC3 interacts with
Ptc1. To this end, we assessed the binding of a soluble GPC3-Al-
kaline Phosphatase fusion protein (GPC3-AP) to membrane
extracts of 293T cells expressing Ptc1, and we performed
GPC3-Ptc1 coimmunoprecipitation experiments. In both exper-
iments, under conditions in which binding of Shh to Ptc1 and
GPC3 was clearly detected, we did not find significant GPC3-
Ptc1 interaction (see Figure S1 in the Supplemental Data avail-
able with this article online).
GPC3 Competes with Ptc1 for the Binding
of Hh at the Cell Surface
The fact that GPC3 interacts with high affinity with Shh but not
with Ptc1 is consistent with the hypothesis that GPC3 acts as
a competitive inhibitor of the Shh-Ptc1 interaction. To provide
more direct experimental support to this hypothesis, we investi-
gated whether GPC3 expression reduces the amount of Hh that
binds to Ptc1. To this end, Light II cells were transfected with dif-
ferent amounts of GPC3 andwere then incubatedwith Shh-AP at
4C. After washing the unbound material, cells were lysed, Ptc1
was immunoprecipitated, and the amount of Shh-AP that coim-
munoprecipitated with Ptc1 was quantified by measuring the AP
activity associated with the precipitated material. As shown in
Figure 4A, we found that increasing the expression of GPC3 re-
duces the binding of Shh-AP to Ptc1. This reduction in binding is
not as pronounced as the GPC3-induced reduction in Hh signal-
ing showed in the luciferase reporter assay (Figure 1). It should
be noted, however, that endogenous Ptc1 from untransfected
cells will still form Ptc1-Shh-AP complexes, whereas untrans-
fected cells do not contribute to the outcome of the luciferase
reporter assay. In fact, the competition for binding with Ptc1 of
Hip1 was similar to that produced by GPC3 (Figure 4B). We con-
clude therefore that GPC3 inhibits Hh signaling by competing
with Ptc1 for Hh binding. If this model is correct, GPC3 should
not be able to inhibit the Hh signaling pathway when such
pathway is stimulated downstream of Ptc1. Consistent with
this, transient expression of GPC3 in Light II cells did not inhibit
signaling activity in a Gli-reporter luciferase assay when the
pathway was activated downstream of Ptc1 by cotransfection
with the gli2 transcription factor (Figure 4C).
GPC3 Mediates Hh Endocytosis and Degradation
There are at least two possible mechanisms by which GPC3
could act as competitive inhibitor of Hh binding to Ptc1 at the
cell membrane (Figure 5A). In the first one, GPC3 and Ptc1bind to the same Shh domain, and, therefore, GPC3 inhibits
the interaction of limiting amounts of Hh to Ptc1 by steric imped-
iment. In the second model, GPC3 binding to Hh does not gen-
erate a steric impediment on the interaction between Ptc1 and
Hh, but the binding of Shh to GPC3 induces the endocytosis of
the Shh-GPC3 complex, reducing the amount of Shh that re-
mains available on the cell surface to bind to Ptc1. In order to
test the steric impediment model, we investigated whether pre-
incubation of Shh with soluble GPC3 inhibits the binding of Shh
to Ptc1, as well as Shh activity as measured by the Gli-reporter
luciferase assay. As shown in Figures 5B and 5C, preincubation
of Shh with increasing amounts of GPC3DGPI-containing condi-
tioned medium did not inhibit the binding of Shh-AP to mem-
brane extracts of 293T cells expressing Ptc1, or the Shh-induced
luciferase activity in Light II cells. In fact, Shh preincubated with
soluble GPC3 induced a slight increase in binding and in lucifer-
ase activity, suggesting that soluble GPC3 can stabilize the inter-
action between Shh and Ptc1. The fact that transient expression
of GPC3 in Light II cells does not inhibit the luciferase activity
induced by Shh that has been preincubated with GPC3DGPI
(Figure 5D) indicates that the GPC3 binding site in Shh has
been properly blocked. Altogether, these experiments indicate
that GPC3 does not inhibit Shh activity by steric impediment.
We next sought to investigate the second model, which
proposes that GPC3 removes Shh from the cell surface by endo-
cytosis and subsequent degradation. GPC3-transfected Light II
cellswere incubatedwithShh-conditionedmediumat 4C, a tem-
perature that is known to inhibit vesicular trafficking. Immunos-
taining with an anti-Shh antibody shows that Shh strongly binds
to the GPC3-expressing cells (Figure 6A, first row). Transfer of
these cells to 37C for 30 or 60 min causes the disappearance
of GPC3 and Shh from the cell membrane and leads to the ap-
pearance of these proteins in the cytoplasmic/perinuclear region,
with a staining pattern that indicates colocalization (Figure 6A,
second and third row). This staining pattern is not observed
when GPC3-expressing cells are incubated in similar conditions
with control-conditioned medium (Figure 6B). These results
strongly suggest that GPC3 is able to mediate Shh internalization
and indicate that the binding of Shh to GPC3 is required to trigger
GPC3 endocytosis. To characterize the subcellular localization of
the internalized Shh-GPC3, we performed an internalization as-
say in the presence of Alexa Fluor 555-conjugated Transferrin
(TF), a well-characterized marker of early endosomes. Figure 6C
shows that whereas at 4C GPC3 and TF are detected at the cell
membrane, after transferring the cells at 37C for 30min, a signif-
icant proportion of the GPC3-positive granules costain with TF-
containing early endosomes, indicating that the GPC3-Shh com-
plex and TF internalize through a similar endocytic pathway
(Movie S1). The presence of GPC3-positive granules that do
not costain with TF may be due to the fact that transfected
GPC3 levels are higher than those of the endogenous TF recep-
tor. Next, to determine whether the Shh-GPC3 complexes are di-
rected to the late-endosome/lysosome compartment for degra-
dation, the internalization assay was prolonged for 1 hr at 37C,
and the presence of Shh and GPC3 in this compartment was as-
sessed by coimmunostaining with Lamp-1, a marker of the late-
endosome/lysosome compartment. As shown in Figure 6D (60
min), after 1 hr at 37C, internalized GPC3 partially overlaps
with Lamp1, indicating that GPC3-Shh complexes are followingDevelopmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc. 703
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(A) Shh-GPC3 coimmunoprecipitation. 293T cells were transfected with the indicated expression vectors, and GPC3 or CEA was immunoprecipitated. Top
panels: The presence of Shh in the precipitated material was probed with an anti-Shh antibody. Middle and bottom panels: The amount of ectopic GPC3,
CEA, and Shh in whole-cell lysates was assessed by western blot. WB, western blot; IP, immunoprecipitation.
(B and C) Binding of the Shh-AP fusion protein or AP alone to membrane extracts prepared from 293T cells transfected with the indicated vectors. The bars
represent the average binding + SD of quadruplicate determinations. The background binding to extracts from cells transfected with vector control (EF) was704 Developmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc.
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the staining patterns of GPC3 and Lamp-1 do not overlap when
cells are kept at 0C (Figure 6D, 0 min).
These results are consistent with a model in which GPC3 in-
hibits Hh signaling by competing with Ptc1 for Hh binding at
the cell surface. The binding of Shh to GPC3 then induces endo-
cytosis and subsequent lysosomal degradation. The fact that
GPC3-Syn fusion protein binds Shh at the cell surface but is
unable to mediate its endocytosis (Figure S2A) indicates that
GPC3-mediated Shh internalization and degradation are crucial
for the inhibitory effect of GPC3 on Hh signaling. Consistent with
this, we observed that GPC3 core protein, which displays Hh-in-
hibitory activity in the Gli-luciferase assay, was able to induce
Shh endocytosis (Figure S2B).
The presence of GPC3 in the lysosomes (as shown by coloc-
alization with Lamp-1) indicates that GPC3 is also degraded. The
fact that the levels of ectopic GPC3 in Light II cells treated with
Shh-conditioned medium are lower than those in control-condi-
tioned medium-treated cells (Figure 6E) provides additional sup-
port to a model in which Shh binding triggers GPC3 endocytosis
and degradation.
GPC3 Null Mice Display Increased Levels of Shh
If the proposed endocytosis/degradation model is correct, it
would be expected that GPC3 null embryos display higher Hh
levels than the normal littermates. To test this, Shh levels were
assessed by western blot in whole-embryo lysates. Figure 7A
shows that Shh expression is significantly higher in mice that
lack GPC3. Moreover, immunohistochemical analysis of Shh
expression in embryo sections also revealed significantly
increased Shh levels in the floor plate of the neural tube, the hind-
gut of E10.5 day embryos, and duodenum and digits of E16.5
day GPC3 null embryos (Figures 7B–7E). All these tissues
express GPC3 (Pellegrini et al., 1998). We also investigated
whether Gli1, a target of the Hh signaling pathway, is increased
in the tissues overexpressing Shh. As shown in Figures 7D and
7E, we found by using immunohistochemistry that Gli1 is signif-
icantly elevated in the digits and the duodenum of the GPC3 null
mice. Gli1 was not detectable in the neural tube and hindgut of
the wild-type or the mutant mice (data not shown). The fact
that Shh mRNA levels are similar in the GPC3 null mouse em-
bryos and normal littermates (Figure 7F) is consistent with our
conclusion that the increased levels of Shh protein in the GPC3
null mice are due to a reduction of Shh endocytosis/degradation,
and not the result of increased Shh mRNA production.
DISCUSSION
In this study, we have identified GPC3 as an inhibitor of Hh sig-
naling during embryonic development. Furthermore, we haveshown that GPC3 acts as a competitive inhibitor of the binding
of Hh to Ptc1 at the cell membrane and that the interaction be-
tween GPC3 and Hh induces the endocytosis and subsequent
lysosomal degradation of the GPC3-Hh complex. Our finding
that Shh protein levels, but not the corresponding transcript,
are increased in the GPC3 null mice is consistent with the role
of GPC3 in the degradation of Shh. Shh accumulation in tissues
lacking GPC3may be the cause of the hyperactivation of Hh sig-
naling and the consequent increased proliferation. For example,
the expansion of the floor plate and duodenum observed in the
GPC3 null embryos may be the consequence of such
Figure 4. GPC3 Competes with Ptc1 for Shh Binding
(A and B) Reduced binding of Shh to Ptc1 in the presence of GPC3 or Hip1.
Cells were transfected with increasing amounts of GPC3 (A) or Hip1 (B) and
vector alone (EF or pCMV6), and were incubated during 2.5 hr at 4C with
Shh-AP or AP. After washing the unbound material, Ptc1 was immunoprecip-
itated, and the amount of Shh-AP bound to the immunoprecipitated Ptc1 was
determined by measuring AP activity. Bars represent the relative amount of
Shh-AP bound to Ptc1 after subtraction of the binding measured for AP
(average + SD of triplicates). One representative experiment of four is shown.
Western blot analysis of the corresponding immunoprecipitated Ptc1 is shown
at the bottom.
(C) Cells were transfected with GPC3 or vector alone (EF). Shh signaling was
stimulated as indicated and luciferase activity was measured. Bars represent
the relative activity, as percentage of the luciferase activity measured after
transfection with vector control (EF). Results represent the average + SD of
triplicates. The experiment was repeated three times with similar results.subtracted from eachmeasurement. The experiments were performed four timeswith similar results. *, indicates statistically significant difference fromEF (B) and
MSCV (C) (p < 0.05).
(D) Binding of Shh (green) to GPC3- or GPC3DGAG- expressing cells (red) *, GPC3-transfected cells.
(E–H) SPR analysis of theGPC3-Shh interaction. GPC3DGPI (E) or GPC3DGAGDGPI (F) was immobilized in the flow cells on streptavidin-coated SA sensor chips,
and various concentrations of Shh (bottom to top: 30, 60, 120, 240, 480 nM) were injected. As control, binding of Shh to SA-coated chip (G) or BSA (same
concentrations) to GPC3-flow cell (H) was determined. The nonspecific binding was subtracted from the sensorgram. RU, relative units. Bottom: ka, kd, and
Kd values were determined using a 1:1 Languimuir binding model with mass transfer. The values for each ligand are expressed as the mean ± SE of five different
concentrations.Developmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc. 705
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teraction between Hh and Ptc1 have been previously described,
including CDO, Boc, Gas1,Megalin, andHh-interacting protein 1
(Hip1) (McCarthy et al., 2002; Allen et al., 2007; Yao et al., 2006;
Zhang et al., 2006; Chuang et al., 2003). Given the crucial role
that the Hh signaling pathway plays during embryonic morpho-
genesis, it is not surprising that the interaction of Hh and Ptc1
is regulated by various proteins that play their role in a time-
and tissue-specific manner during development. Like GPC3,
Hip1 is a membrane-bound negative regulator of Hh (Chuang
and McMahon, 1999). It has been proposed that Hip1 prevents
the interaction of Hh with Ptc1, but, unlike GPC3, it seems that
Figure 5. Shh Can Bind Simultaneously to
GPC3 and Ptc1
(A) Model for the inhibitory effect of GPC3 on Hh
signaling. In the absence of GPC3 (left), all the
available Hh can bind to Ptc1 to induce a certain
amount of signaling (arrows). GPC3 could inhibit
Hh signaling by two mechanisms (right): (1) Hh
binds to Ptc1 and GPC3 at the same or a close
binding site, leading to a steric impediment; (2)
binding of Hh to GPC3 triggers to the internaliza-
tion and posterior degradation of the complex
leading to a decrease of Hh levels at the cell
membrane.
(B) Shh binding assay. Binding of Shh-AP to mem-
brane extracts prepared from 293T cells. Cells
were transfected with Ptc1, and membrane ex-
tracts were exposed to Shh-AP that had been pre-
incubated with the indicated conditioned medium.
The bars represent the relative binding compared
to control medium (EF). Bars represent the aver-
age + SD of quadruplicate determinations. The ex-
periment was repeated twice with similar results.
(C) Shh-induced luciferase reporter assay after
Shh- or control-conditioned media were preincu-
bated with GPC3DGPI- or EF-conditioned media.
Bars represent fold stimulation induced by Shh.
Each sample was assessed by triplicates and the
results represent the average + SD. The experi-
ment was repeated four times with similar results.
(D) Shh-induced luciferase reporter assay in cells
transfected with the indicated expression vectors.
Shh- or control-conditioned media were preincu-
bated with GPC3DGPI- or EF-conditioned media
(1:1) before addition to transfected cells. Bars rep-
resent the relative luciferase activity induced by
Shh, considering the activity of Shh+EF on
EF-transfected cells as 100%. Bars represent
the average + SD of triplicate determinations.
The experiment was repeated three times with
similar results.
Hip1 is not a strong promoter of endocy-
tosis (Jeong and McMahon, 2005).
One of the two Drosophila glypicans,
Dally-like protein, has been previously
implicated in the regulation of Hh signal
reception in a cell-autonomous manner
(Lum et al., 2003). Unlike GPC3, however,
Dally-like protein was shown to act as
a positive regulator of Hh signaling. The
other Drosophila glypican, Dally, did not display any Hh-regula-
tory activity (Lum et al., 2003). The precise mechanism by which
Dally-like-protein stimulates Hh signaling, and the molecular ba-
sis of the differential effect of the two Drosophila glypicans, are
currently unknown.
As expected for a signaling pathway that has to be turned on
and off at different time points during development, the Hh sig-
naling pathway displays various negative and positive feedback
loops. For example, Hh signaling stimulates the expression of
Ptc1 and Hip1, two inhibitors of Hh signaling which act as nega-
tive feedback loops (Chuang et al., 2003; Chen and Struhl, 1996).
Interestingly, a recent genome-wide search for Hh-responsive706 Developmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc.
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element containing two Gli-binding sites in the GPC3 promoter
region, suggesting that GPC3 could represent an additional
negative feedback loop of the Hh signaling pathway (Hallikas
et al., 2006).
We and others have previously reported that GPC3 can stim-
ulate canonical and noncanonical Wnt signaling (Capurro et al.,
2005; Topczewski et al., 2001; Song et al., 2005). Although the
molecular basis of this Wnt-stimulatory activity is not completely
understood, the fact that glypicans can bind to Wnt and to its
receptor Frizzled (Ohkawara et al., 2003; Capurro et al., 2005)
has led to the speculation that GPC3 acts to facilitate/stabilize
the interaction between Wnt and Frizzled by forming a tripartite
complex (Capurro et al., 2005). In the case of Hh, however, we
have shown here that GPC3 interacts with high affinity with Hh,
but not with its receptor, Ptc1. This is consistent with the Hh-in-
hibitory activity of GPC3 described in this study.
Another important finding of this work is that the core protein
of GPC3 can directly interact with Shh. This was demonstrated
by using coimmunoprecipitation, binding assays, and SPR.
The SPR experiments, in particular, showed that, unlike the inter-
action between Shh and heparan sulfate (HS) (Zhang et al.,
2007), the binding of the GPC3 core protein to Shh displays
high affinity. Our biochemical findings are consistent with previ-
ous genetic experiments in Drosophila which showed that ec-
topic Hh can rescuemutants that cannot synthesize HS, but can-
not rescue the phenotype of embryos that have been depleted
of Dally-like protein by RNAi (Desbordes and Sanson, 2003).
Although our SPR studies showed that the GPC3 core protein
binds to Shh with similar affinity as the glycanated GPC3, our
transient expression assays suggest that the HS are required
for optimal signaling. We also showed that the HS chains are
not required to mediate Hh endocytosis. Whether the HS chains
increase Hh inhibition by inducing the proper localization of
GPC3 or by regulating the rate of endocytosis remains to be
elucidated.
We have shown in this study that the inhibitory effect of GPC3
on Hh activity requires attachment to the cell surface through
a GPI anchor. The fact that the GPC3-Syn1 fusion protein is
able to bind Hh but does not induce its internalization indicates
that the GPI anchor is essential for the GPC3-induced inhibition
of Hh signaling.
The Hh andWnt signaling pathways display numerous similar-
ities, including the common use of glycogen synthase kinase-3
and casein kinase-1 (Nusse, 2003). In this regard, it is important
to note that we have previously reported that the GPC3 core pro-
tein can form complexes with several Wnts, and that this glypi-
can can stimulate Wnt signaling (Song et al., 2005; Capurro
et al., 2005). Thus, GPC3 should be added to the list of proteins
that are part of both the Wnt and Hh signaling pathways.
Our analysis of the GPC3 null embryos has clearly shown that
the Hh pathway is hyperactivated in the absence of GPC3. Be-
cause it has already been demonstrated that global hyperactiva-
tion of Hh signaling during development leads to overgrowth
(Makino et al., 2001; Milenkovic et al., 1999), we can conclude
that GPC3 regulates body size, at least in part, through the Hh
signaling pathway. On the other hand, we have not proven that
GPC3 regulates body size only through the Hh pathway, and at
this point in time we cannot discard the possibility that theDBMP or Wnt pathways mediate part of the regulatory activity of
GPC3 on body size. A definitive proof for an exclusive role
of the Hh signaling pathway in the growth-regulatory activity of
GPC3 would require the crossing of GPC3 null mice with mice
in which the Hh signaling pathway has been abrogated. Unfortu-
nately, mice without Hh signaling die at a very early stage of
development. For example, Smoothened mutants die at E9.5
(Zhang et al., 2001), and Ptc1 mutants at E8.5, well before
GPC3 starts to play a regulatory role in body size (Chiao et al.,
2002). In the case of Shh- and Ihh-deficient mice, the phenotype
is not so severe, and some embryos complete development
(Chiang et al., 1996; St-Jacques et al., 1999). However, Shh
and Ihh have redundant roles and theHh signaling pathway is still
active in these mutants (Zhang et al., 2001). The Shh and Ihh
compound mutants die at E8.5 (Zhang et al., 2001) and, like
the Smo and Ptc1mutants, cannot be used to study the connec-
tion between GPC3 and the Hh signaling pathway.
As described above, SGBS patients display numerous devel-
opmental abnormalities in addition to overgrowth. Whereas the
results presented here suggest that the hyperactivation of
the Hh signaling pathway is responsible for the larger size of the
SGBS patients, whether the activation of this pathway is also
involved in other phenotypic aspects of this syndrome remains
to be investigated. In this regard it should be noted that, in addi-
tion to overgrowth, the SGBS and the Gorlin syndrome display
other common features, including fused ribs, cleft lip/palate,
and polydactyly. Thus it is reasonable to speculate that these ab-
normalities of the SGBS patients are also due to hyperactivation
of Hh signaling. On the other hand, Gorlin syndrome patients and
Ptc1 heterozygote mice display certain features that are not
found in the SGBSpatients and theGPC3nullmice. For example,
unlike SGBS patients, Gorlin patients display predisposition to
medulloblastomas and basal cell carcinomas (Gorlin, 1995).
These differences are likely due to the fact that GPC3 is not nor-
mally expressed in adult skin or in adult nervous system. SGBS
patients and GPC3 null mice also display abnormalities that are
not seen inGorlin patients and in Ptc1 heterozygotemice, includ-
ing kidney dysplasia and abnormal lung development (Cano-
Gauci et al., 1999). It is possible that these unique features are
due to the role of GPC3 in the regulation of Wnt signaling
during development (Song et al., 2005). In addition, at this
point in time, we cannot discard the possibility that GPC3 may
regulate BMP and/or FGF signaling at least in some embryonic
tissues.
EXPERIMENTAL PROCEDURES
Quantitative RT-PCR
Mice were genotyped as previously described (Cano-Gauci et al., 1999). Total
RNA was isolated, and cDNA was then generated by reverse transcription
using oligo(dT)12-18 primers (Invitrogen). Quantification of Ptc1, Gli1, and Shh
mRNA expression was performed with the ABI Prism 7000 Sequence Detec-
tion System using QuantiTect SYBR Green (QIAGEN). Data were normalized
against the transcript levels of b-actin. Sequences of primers are shown in
Supplemental Data.
Cell Lines and Transfection
293T, NIH 3T3, and Light II cells (ATCC) were cultured in DMEM supplemented
with 10% FBS and transfected with Lipofectamine 2000 (293T) and Lipofect-
amine Plus (NIH 3T3 and Light II) (Invitrogen). All conditioned media were
prepared in 293T cells after transfection with the indicated expression vectors.evelopmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc. 707
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(A–D) GPC3-Shh internalization studies. Cells transfected with GPC3 were incubated with Shh-containing conditioned medium (A, C, and D) or control-
conditioned medium (B) for 1 hr at 4C, and transferred for the indicated time periods at 37C before processing for fixation and immunostaining. Bars: 15 mm.
(A) Staining for GPC3 (red), Shh (green). Yellow in merged pictures indicates colocalization.
(B) GPC3 immunostaining is shown in red.
(C) Cells were incubated simultaneously with Shh and Alexa Fluor555-conjugated transferrin (TF). Merged picture with GPC3 (green) and TF (red) staining is
shown. Arrows in the 30 min panel inset indicate GPC3-TF colocalization.
(D) Merged pictures of GPC3 (green) and Lamp1 (red) immunofluorescence are shown for the indicated time points. For 0 min, higher magnification panels of
green and red channels are included. Arrowheads in the 60 min panel inset indicate GPC3-Lamp1 colocalization.708 Developmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc.
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presence of 2% FBS conditions. Information on vectors is provided in
Supplemental Data.
Gli Reporter Assay
NIH 3T3 cells were seeded in six-well plates (220,000 cells/well) and trans-
fected with the indicated expression vectors. One day after transfection, cells
Figure 7. Increased Hh Levels in GPC3 Null Mice
(A)Western blot analysis of Shh levels inwhole-embryo lysates of the indicated genotype usingCDK4 as loading control. Three independent litterswith a total of six
wild-type and eight GPC3-KOmice were analyzed. One representative litter is shown. Bands were scanned and quantified by a densitometer. Average density +
SD of Shh/CDK4 ratio for the indicated genotype is shown on the right.
(B–E) Immunohistochemical analysis of Shh andGli1 expression in embryo sections of the indicated genotypes and stages. Transversal sections to visualize neural
tube and notochord (B), hindgut (C), and sagittal sections that include the duodenum (D) and digits (E) are shown. (F) Relative levels of Shh transcripts determined
by real-time PCR using b-actin transcript levels as reference. Two independent litters with a total of five WT and seven GPC3-KO mice were analyzed. For each
litter, the relative expression level for each transcript was normalized considering the lower wild-type value as 1. All ratios were then plotted together. The bars
represent the mean + SD for the indicated genotype.(E) Western blot analysis of GPC3 levels in GPC3-transfected Light II cells treated overnight with Shh (+)- or control ()-conditionedmedium. b-actin was used as
loading control.Developmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc. 709
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ShhN- or control-conditioned medium (diluted 1/10 in DMEM-2% FBS) was
added for 48 hr. Alternatively, NIH 3T3 cells were cocultured with 293T cells
transfected with an Ihh expression vector or vector control (250,000 cells/
well). The Luciferase assay was then performed. Activities were normalized
based on b-galactosidase activity.
Western Blot Analysis
E11.5 embryos were dissected out of their yolk sacs and genotyped. Embryos
extracts were prepared as described (Song et al., 2005), and the levels of Shh
and CDK4 were assessed by western blot. Information on antibodies can be
found in Supplemental Data.
Coimmunoprecipitation
293T cell lysateswere preparedwith RIPA buffer and preclearedwith protein G
Sepharose. GPC3, CEA, or Ptc1 was immunoprecipitated from lysates over-
night at 4C, and protein G Sepharose beads were then added. The presence
of Shh, GPC3, or Ptc1 in the precipitated material was analyzed by western
blot.
Alkaline Phosphatase-Ligand Binding Assay
293T cells transfected with the indicated expression vectors were homoge-
nized in 10 mM Tris-HCl (pH 7.4), 1.5 mM EDTA, and 0.5 mM DTT with an
11/2/25G needle-containing syringe. The cell homogenate was centrifuged
at 3000 rpm for 10 min, and the membrane fraction was isolated from the
supernatant by ultra-centrifugation in a Beckman SW60 rotor at 27,000 rpm
for 90 min. The membrane-containing pellet was then solubilized in PBS
with 1% NP40 during 15 min on ice. To perform the binding assay, 96-well
plates were covered with membrane extracts (10 mg/well) overnight at 37C.
After blocking with BSA (10 mg/ml in PBS), Shh-AP, GPC3-AP, or AP con-
trol-conditioned media containing the same amount of alkaline phosphatase
(AP) activity was added to the wells and incubated overnight at 4C. The wells
were then washed five times for 10 min with BSA (1 mg/ml) in PBS containing
0.05% Tween-20, and the AP activity was measured with a Sigma fast p-nitro-
phenyl phosphate tablet set.
Surface Plasmon Resonance Analysis
The kinetic constants of the interaction of Shh with GPC3 or GPC3DGAGwere
evaluated using a BIAcore 3000 biosensor system. The His-tagged soluble
form of GPC3 (GPC3DGPI/His) or nonglycanated GPC3 (GPC3DGAGDGPI/
His) were biotinylated with EZ-LinkSulfo-NHS-LC-Biotin (Pierce) and individu-
ally immobilized (500 RU) in flow cells 2 and 3 on a SA sensorchip (BIAcore AB).
Flow cell 1 without ligand was used as a correction reference for nonspecific
binding. The indicated concentrations of Shh (R&D) or bovine serum alumin
(BSA) in running buffer HBS-EP (BIAcore AB) were injected over these flow
cells at 30 ml/min for 90 s at 25C. After a 3 min wash with HBS-EP, the flow
cells were regenerated with 1 min pulses of HBS-EP containing 1 M NaCl
and 10 mM NaOH.
Endocytosis Assay
Cells were plated on coverslips and transfected with the indicated expression
vectors. Two days after transfection, cells were starved in serum-free medium
during 1.5 hr and were then incubated with Shh- or control-conditioned
medium supplemented with 1% BSA during 1 hr at 4C. Unbound ligand
was removed by washing, and cells were transferred to 37C for the indicated
time periods and then fixed with 4%paraformaldehyde.When indicated, Alexa
Fluor 555-conjugated Transferrin (Invitrogen) at 20 mg/ml was added to the
Shh-conditioned medium. For staining, cells were permeabilized with 0.1%
Triton X-100 for 15 min at room temperature and blocked during 1 hr with
5% nonfat dry milk in PBS+ (blocking buffer). All incubations with primary
and secondary antibodies were performed during 1 hr at room temperature
in blocking buffer followed by three washes with PBS+, 10 min each. Informa-
tion on antibodies can be found in the Supplemental Data.
Immunohistochemical Analysis of GPC3 Null and Wild-Type
Littermate Embryos
Shh and Gli1 expression was analyzed on paraffin-embedded embryo sec-
tions, prepared from E10.5 and E16.5 GPC3 null and normal littermates710 Developmental Cell 14, 700–711, May 2008 ª2008 Elsevier Inc.following standard procedures. Three independent litters were analyzed for
E10.5 and E16.5 embryonic stage. Representative sections are shown.
SUPPLEMENTAL DATA
Supplemental Data include two figures, twomovies, and Supplemental Exper-
imental Procedures and can be found with this article online at http://www.
developmentalcell.com/cgi/content/full/14/5/700/DC1/.
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